Published in Cancer Weekly, January 5th, 2010
"Met receptor and its ligand, HGF, are commonly overexpressed in NSCLC, and their...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.